Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Third gasotransmitter garners interest

This article was originally published in Scrip

Executive Summary

Twenty years ago, three US researchers were awarded the Nobel Prize in Physiology or Medicine for their discoveries concerning nitric oxide (NO) as a signalling molecule in the cardiovascular system. Until then, NO had been looked upon mainly as an air pollutant, and its identification as a signalling molecule was particularly surprising as chemically it was totally unlike any other signalling molecule known at the time. The researchers discovered that NO was rapidly converted to nitrite and nitrate within the body: suddenly, the use of nitrates to treat conditions such as angina made a lot more sense.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC003692

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel